Delivery Order SPE2DB24D9212-SPE2DB24FBUDN

Award Date 9/6/24
Potential Completion Date 9/27/24
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,409.76 firm fixed-price delivery order is for the supply of NEXPLANON 68 mg implants, a contraceptive product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $3,573.45 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The award is part of a larger indefinite delivery contract (IDC) under the DLA's SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,573.45 firm fixed-price delivery order is for the supply of 68 mg NEXPLANON implants, a contraceptive product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the purchase of NEXPLANON 68 MG IMPLANTS, a contraceptive device. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,720.35 firm fixed-price delivery order contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract has an ultimate completion date of August 6, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,226.48 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with an ultimate completion date of August 25, 2021. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,204.88 firm fixed-price delivery order is for the supply of Nexplanon 68 mg implants, a contraceptive device. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities worldwide. The award is not associated with a set-aside program. This...
  • SPE2DB24D9212
    Indefinite Delivery Contract
  • SPE2DB24D9212-SPE2DB24FBUDN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the supply of 4565775288 NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the diverse medical requirements of DoD healthcare facilities worldwide. The contract does not have a set-aside designation.

Generated 12/6/24, 9:17 AM